1. Home
  2. Health
  3. Arthritis

Q & A: FDA Regulatory Actions on COX-2 Inhibitors & NSAIDs

Part 5 of 5 - On April 7, 2005, FDA Announced Planned Regulatory Actions

By Carol & Richard Eustice, About.com

Updated: October 4, 2006

About.com Health's Disease and Condition content is reviewed by Kate Grossman, MD

Question #17) If I’m taking Bextra, what should I do?

We encourage people taking Bextra to contact their physician to discuss discontinuing use and alternative treatments. Any decision about which drug product to take to treat your symptoms should be made in consultation with your physician based on an assessment of your specific treatment needs.

Question #18) If I have rheumatoid arthritis, what pain medication does FDA recommend?

You should consult your doctor to discuss the best course of action.

Call Drug Information at: 888-INFO-FDA (888-463-6332)

Question #19) How can I report serious side effects with COX-2 selective and non-selective NSAIDs to FDA?

FDA encourages anyone aware of a serious adverse reaction to make a MedWatch report. You can report an adverse event in two ways:

  • Visit www.fda.gov/medwatch and click on "How to Report"
  • Call 1-800-FDA-1088
  • Question #20) Where can I get more information?

    To find out more about all NSAIDs from FDA:

    Visit our Drug Information web page at: www.fda.gov/cder

    Call Drug Information at: 888-INFO-FDA (888-463-6332)

    Source: Questions and Answers: FDA Regulatory Actions for the COX-2 Selective and Non-Selective Non-Steroidal Anti-inflammatory drugs (NSAIDs), FDA/Center for Drug Evaluation and Research, April 7, 2005

    Go Back To Part 1 --- FDA Regulatory Actions --->

    Explore Arthritis

    More from About.com

    About.com is accredited by the Health On the Net Foundation, which promotes reliable and trusted online health information.
    1. Home
    2. Health
    3. Arthritis
    4. Arthritis Medications
    5. A - Z: NSAIDs
    6. Q & A: FDA Actions on COX-2 Inhibitors & NSAIDs (Nonsteroidal Anti-Inflammatory Drugs)

    ©2008 About.com, a part of The New York Times Company.

    All rights reserved.